Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer

Gynecologic Oncology

Volumn 66, Issue 1, 1997, Pages 103-107

  Eltabbakh, Gamal H ^a   Steven Piver, M ^a   Hempling, Ronald E ^a   Recio, Fernando O ^a   Aiduk, Christine ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; ENDOMETRIUM BIOPSY; ESTROGEN THERAPY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; OVARIECTOMY; OVARY CANCER; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPHYLAXIS; UTERUS BLEEDING;

EID: 0031193459     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4723     Document Type: Article

References (16)

1. Hidreth N G, Kelsey J L, LiVolsi V A, Fischer D B, Holford T R, Mostow E D, Schwartz P E, White C. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol. 114:1981;398-405.
2. Nguyen H N, Averette H E, Janicek M. Ovarian carcinoma: a review of the significance of familial risk factors and the role of prophylactic oophorectomy in cancer prevention. Cancer. 74:1994;545-555.
3. Lynch H T, Conway T, Lynch J. Hereditary ovarian cancer pedigree studies: part II. Cancer Genet Cytogenet. 52:1991;161-163.
4. Piver M S, Barlow J J, Sawyer D. Familial ovarian cancer: increasing in frequency? Obstet Gynecol. 60:1982;397-399.
5. Ross R K, Paganini-Hill A, Mack T M, Mack T M, Arthur M, Henderson B E. Menopausal estrogen therapy and protection from death from ischemic heart disease. Lancet. 1:1981;858-860.
6. Stampfer M J, Willet W C, Colditz G A, Rosner B, Speizer F E, Hennekens C H. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 313:1985;1044-1049.
7. Pagganini-Hill A, Ross R K, Gerkins V R, Henderson B E, Arthur M, Mack T M. Menopausal estrogen therapy and hip fractures. Ann Intern Med. 95:1981;28-31.
8. Hammond C B, Jelosek F R, Lee K L, Creasman W T, Parker R T. Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol. 133:1979;525-536.
9. Ravnikar V A. Compliance with hormone therapy. Am J Obstet Gynecol. 156:1987;1332-1334.
10. Bush T L, Coway L D, Barrett-Connor E, Criqui M H, Karon J M, Wallace R B, Tyroler H A, Rifkind B M. Estrogen use and all-cause mortality. Preliminary results from the lipid research clinic follow-up study. JAMA. 249:1983;903-906.
11. Ryan P J, Harrison R, Blake G M, Fogelman I. Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis. Br J Obstet Gynaecol. 99:1992;325-328.
12. Stumpf P G, Trolice M P. Compliance problems with hormone replacement therapy. Obstet Gynecol Clin N Am. 21:1994;219-229.
13. Ettinger B, Grady D. The waning effect of postmenopausal estrogen therapy on osteoporosis. N Engl J Med. 329:1993;1192-1193.
14. Ettinger B, Genant H K, Cann C E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 102:1985;319-324.
15. Ferguson K J, Curtis H, Johnson S. Estrogen replacement therapy: a survey of women's knowledge and attitudes. Arch Intern Med. 149:1989;133-136.
16. Hahn R G. Compliance considerations with estrogen replacement: withdrawal bleeding and other factors. Am J Obstet Gynecol. 161:1989;1854-1858.